Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.03 (+3.43%)
As of: Oct 2, 2026 · 10:22 AM EDT

Rani Therapeutics Holdings (RANI) Other Operating Expenses (2020 - 2024)

Updated

Rani Therapeutics Holdings (RANI) reported Other Operating Expenses of $3.71 million for Q4 2024.

Analysis

Rani Therapeutics Holdings (RANI) Other Operating Expenses (2020 - 2024) Analysis & Trends

  • By year, Other Operating Expenses came in at -$34.01 million in FY2020.
  • The Q4 2024 figure ranks as the lowest quarterly Other Operating Expenses since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.71 Mn
Dec 31, 2020 -34.01 Mn
API Access

Rani Therapeutics Holdings Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=RANI&period=max&api_key=YOUR_API_KEY